This research aims to examine how socioeconomic disadvantage affects the clinical outcomes of patients with inflammatory eye diseases using systemic immunosuppression.
Analyzed time to control of ocular inflammatory disease
Measured socioeconomic disadvantage with the Area Deprivation Index (ADI)
Focused on patients requiring systemic immunosuppression
Patients with greater socioeconomic disadvantage experienced longer times to disease control
The ADI was significantly associated with clinical outcomes
Findings indicate a clear health disparity linked to socioeconomic status
Abstract
Time to control of ocular inflammatory disease with systemic immunosuppression is adversely impacted by greater socioeconomic disadvantage as measured by ADI.